Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 38 studies | 34% ± 15% | |
| pericyte | 30 studies | 45% ± 18% | |
| smooth muscle cell | 21 studies | 28% ± 9% | |
| endothelial cell | 19 studies | 37% ± 16% | |
| endothelial cell of lymphatic vessel | 13 studies | 31% ± 16% | |
| connective tissue cell | 13 studies | 35% ± 10% | |
| myofibroblast cell | 11 studies | 35% ± 14% | |
| adipocyte | 9 studies | 32% ± 13% | |
| astrocyte | 6 studies | 25% ± 13% | |
| adventitial cell | 5 studies | 21% ± 7% | |
| cardiac muscle cell | 5 studies | 24% ± 3% | |
| hepatocyte | 4 studies | 53% ± 24% | |
| hepatic stellate cell | 3 studies | 44% ± 17% | |
| glomerular endothelial cell | 3 studies | 19% ± 1% | |
| glial cell | 3 studies | 31% ± 19% | |
| endothelial cell of sinusoid | 3 studies | 51% ± 32% | |
| muscle cell | 3 studies | 40% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 26100.81 | 457 / 459 | 95% | 84.29 | 1067 / 1118 |
| lung | 100% | 16311.48 | 576 / 578 | 92% | 69.11 | 1058 / 1155 |
| stomach | 96% | 15941.71 | 346 / 359 | 92% | 87.95 | 264 / 286 |
| intestine | 99% | 21445.61 | 952 / 966 | 88% | 52.95 | 464 / 527 |
| esophagus | 86% | 16488.44 | 1247 / 1445 | 96% | 97.81 | 176 / 183 |
| bladder | 100% | 17603.81 | 21 / 21 | 82% | 44.30 | 411 / 504 |
| liver | 85% | 5582.27 | 193 / 226 | 94% | 82.17 | 383 / 406 |
| thymus | 91% | 8346.89 | 596 / 653 | 79% | 33.32 | 480 / 605 |
| uterus | 99% | 20629.54 | 169 / 170 | 69% | 59.73 | 315 / 459 |
| adrenal gland | 91% | 9633.00 | 236 / 258 | 73% | 42.38 | 168 / 230 |
| skin | 76% | 18813.75 | 1373 / 1809 | 88% | 150.10 | 417 / 472 |
| prostate | 87% | 9587.01 | 212 / 245 | 68% | 23.31 | 340 / 502 |
| ovary | 100% | 21530.21 | 180 / 180 | 54% | 20.62 | 232 / 430 |
| kidney | 71% | 6711.35 | 63 / 89 | 81% | 98.01 | 729 / 901 |
| pancreas | 35% | 1871.36 | 116 / 328 | 96% | 72.95 | 171 / 178 |
| adipose | 100% | 30183.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.83 | 1 / 1 |
| blood vessel | 97% | 13848.78 | 1292 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 94% | 10525.03 | 226 / 241 | 0% | 0 | 0 / 0 |
| heart | 92% | 9380.62 | 795 / 861 | 0% | 0 | 0 / 0 |
| brain | 1% | 41.64 | 23 / 2642 | 85% | 53.69 | 597 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 62% | 34.44 | 28 / 45 |
| muscle | 52% | 3281.55 | 417 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 11.03 | 12 / 29 |
| eye | 0% | 0 | 0 / 0 | 26% | 6.54 | 21 / 80 |
| peripheral blood | 8% | 517.96 | 77 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
| GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
| GO_2001046 | Biological process | positive regulation of integrin-mediated signaling pathway |
| GO_0045785 | Biological process | positive regulation of cell adhesion |
| GO_0032836 | Biological process | glomerular basement membrane development |
| GO_0060070 | Biological process | canonical Wnt signaling pathway |
| GO_0071711 | Biological process | basement membrane organization |
| GO_0110011 | Biological process | regulation of basement membrane organization |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0098637 | Cellular component | protein complex involved in cell-matrix adhesion |
| GO_0005604 | Cellular component | basement membrane |
| GO_0017147 | Molecular function | Wnt-protein binding |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0042813 | Molecular function | Wnt receptor activity |
| GO_0043237 | Molecular function | laminin-1 binding |
| GO_0043236 | Molecular function | laminin binding |
| GO_0043394 | Molecular function | proteoglycan binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005518 | Molecular function | collagen binding |
| Gene name | NID1 |
| Protein name | Alternative protein NID1 Nidogen-1 (NID-1) (Entactin) |
| Synonyms | NID |
| Description | FUNCTION: Sulfated glycoprotein widely distributed in basement membranes and tightly associated with laminin. Also binds to collagen IV and perlecan. It probably has a role in cell-extracellular matrix interactions. |
| Accessions | L8EC96 ENST00000264187.7 [P14543-1] P14543 ENST00000366595.7 [P14543-2] |